Yiwei Cheng

iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding.

Kunming Zhao, C. Zhang, Xuting Xue, 2017, Cancer cell.

HDAC1-induced epigenetic silencing of ASPP2 promotes cell motility, tumour growth and drug resistance in renal cell carcinoma.

Kunming Zhao, C. Zhang, Yao Zhang, 2018, Cancer letters.

Differential Notch1 and Notch2 expression and frequent activation of Notch signaling in gastric cancers.

Jia Liu, Xiao-yan Chen, Hong Li, 2011, Archives of pathology & laboratory medicine.

Epigenetic silencing of ASPP1 confers 5‐FU resistance in clear cell renal cell carcinoma by preventing p53 activation

Kunming Zhao, Qinghua Jiang, Xiaoliang Wu, 2017, International journal of cancer.